Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

被引:175
|
作者
Ong, J
Younossi, ZM
Reddy, V
Price, LL
Gramlich, T
Mayes, J
Boparai, N
机构
[1] Inova Fairfax Hosp, Ctr Liver Dis, Dept Med, Falls Church, VA 22042 USA
[2] Cleveland Clin Fdn, Dept Gastroenterol, Anat Pathol & Transplant Ctr, Cleveland, OH 44195 USA
关键词
D O I
10.1053/jlts.2001.24644
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Some patients diagnosed with cryptogenic cirrhosis may have "burned-out" nonalcoholic fatty liver disease (NAFL). To test this hypothesis, we used our liver transplant database (November 1984 to November 1998) to assess the incidence of NAFL in patients with cryptogenic cirrhosis after orthotopic liver transplantation (OLT). We also examined the clinicodemographic features associated with post-OLT NAFL, obtained by chart review and telephone interviews. When available, post-OLT liver biopsy specimens were reviewed blindly by a hepatopathologist according to the NAFL pathology protocol. We identified 51 patients with cryptogenic cirrhosis (mean age, 51 +/- 12 years); 60% were women, 94% were white, and 34% had type 2 diabetes mellitus (DM). Mean pre-OLT body mass index (BMI) was 27.33 +/- 5.54 kg/m(2). Twenty-five patients underwent at least 1 post-OLT liver biopsy. Post-OLT NAFL was identified in 13 patients (25.4%), whereas post-OLT nonalcoholic steatohepatitis (NASH) was seen in 8 patients (15.7%). Features associated with post-OLT NASH were pre- and post-OLT type 2 DM (P less than or equal to .05) and an elevated fasting triglyceride level (P < .05). BMI tended to be greater in patients with post-OLT NAFL or NASH. Those who did not develop post-OLT NAFL showed a decrease in BMI. Patients with cryptogenic cirrhosis undergoing OLT resemble patients with NAFL. Post-OLT NAFL and NASH can be seen in a number of patients with cryptogenic cirrhosis. This supports the notion that some cases of cryptogenic cirrhosis represent burned-out NAFL.
引用
收藏
页码:797 / 801
页数:5
相关论文
共 50 条
  • [21] A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
    Cyrielle Caussy
    Anupriya Tripathi
    Greg Humphrey
    Shirin Bassirian
    Seema Singh
    Claire Faulkner
    Ricki Bettencourt
    Emily Rizo
    Lisa Richards
    Zhenjiang Z. Xu
    Michael R. Downes
    Ronald M. Evans
    David A. Brenner
    Claude B. Sirlin
    Rob Knight
    Rohit Loomba
    Nature Communications, 10
  • [22] Association of Elevated Liver Enzymes With Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
    Amjad, Waseem
    Verduzco, Esteban
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (01) : 204 - 205
  • [23] Liver Transplant Outcomes in Young Adults with Cirrhosis Related to Nonalcoholic Fatty Liver Disease
    Bezinover, Dmitri
    Alhkouri, Naim
    Schumann, Roman
    Geyer, Nathaniel
    Chinchilli, Vernon
    Stine, Jonathan G.
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (09) : 2134 - 2142
  • [24] Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease
    Wong, Vincent Wai-Sun
    Vergniol, Julien
    Wong, Grace Lai-Hung
    Foucher, Juliette
    Chan, Henry Lik-Yuen
    Le Bail, Brigitte
    Choi, Paul Cheung-Lung
    Kowo, Mathurin
    Chan, Anthony Wing-Hung
    Merrouche, Wassil
    Sung, Joseph Jao-Yiu
    de Ledinghen, Victor
    HEPATOLOGY, 2010, 51 (02) : 454 - 462
  • [25] Nonalcoholic Fatty Liver Disease Is Related to Nonalcoholic Fatty Pancreas Disease
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C. M. A.
    van der Peet, Donald L.
    Bloemena, Elisabeth
    Mulder, Chris J. J.
    PANCREAS, 2010, 39 (08) : 1185 - 1190
  • [26] Aneuploidy and asynchronous replication in non-alcholic fatty liver disease and cryptogenic cirrhosis
    Laish, Ido
    Mannasse-Green, Batya
    Hadary, Ruth
    Konikoff, Fred M.
    Arnie, Aliza
    Kitay-Cohen, Yona
    GENE, 2016, 593 (01) : 162 - 166
  • [27] RACIAL DISPARITIES IN PREVALENCE OF CIRRHOSIS AND EXTRAHEPATIC MANIFESTATIONS IN NONALCOHOLIC FATTY LIVER DISEASE
    Aboona, Majd B.
    Faulkner, Claire S.
    Rangan, Pooja
    Chen, Vincent L.
    Kim, Donghee
    Ng, Cheng Han
    Li, Fang
    Rubin, Moises I. Nevah
    Han, Ma Ai Thanda
    Fallon, Michael B.
    Wijarnpreecha, Karn
    GASTROENTEROLOGY, 2023, 164 (06) : S1308 - S1308
  • [28] Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
    Moylan, Cynthia A.
    Abdelmalek, Manal F.
    HEPATOLOGY, 2018, 68 (04) : 1646 - 1648
  • [29] Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
    Caussy, Cyrielle
    Soni, Meera
    Cui, Jeffrey
    Bettencourt, Ricki
    Schork, Nicholas
    Chen, Chi-Hua
    Al Ikhwan, Mahdi
    Bassirian, Shirin
    Cepin, Sandra
    Gonzalez, Monica P.
    Mendler, Michel
    Kono, Yuko
    Vodkin, Irine
    Mekeel, Kristin
    Haldorson, Jeffrey
    Hemming, Alan
    Andrews, Barbara
    Salotti, Joanie
    Richards, Lisa
    Brenner, David A.
    Sirlin, Claude B.
    Loomba, Rohit
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (07): : 2697 - 2704
  • [30] INCREASING INCIDENCE AND PREVALENCE OF HCC AND CIRRHOSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Samuel, Ronald
    Ali, Basim
    Kramer, Jennifer
    Cao, Yumei
    Cholankeril, George
    Hernaez, Ruben
    Lee, Tzu-Hao
    El-Serag, Hashem B.
    Kanwal, Fasiha
    HEPATOLOGY, 2023, 78 : S987 - S987